dihexa safety concerns hgf c-met cancer risk Frontiers Targeting cancer-associated fibroblast-activated HGF/c-MET pathway
Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Targeting c MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications PMC Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Frontiers The Function of the HGF c Met Axis in Hepatocellular Carcinoma
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



